open access

Vol 72, No 4 (2014)
Original articles
Published online: 2014-04-09
Get Citation

Aspirin resistance in patients with impaired renal functions

Hale Unal Aksu, Ender Oner, Mehmet Erturk, Huseyin Aksu, Nilgun Isıksacan, Begum Ozalp, Gulsah Akture, Ertan Akbay, Leyla Ozer, Mustafa Kemal Erol
DOI: 10.5603/KP.a2013.0286
·
Kardiol Pol 2014;72(4):331-338.

open access

Vol 72, No 4 (2014)
Original articles
Published online: 2014-04-09

Abstract

Background: Cardiovascular diseases (CVD) are the leading cause of death in patients with chronic kidney diseases (CKD). Aspirin resistance (AR) worsens prognosis in CVD.

Aim: The aim of this study was to detect AR prevalence in this patient group.

Methods: The 203 patients (mean age 61.84 ± 11.51 years, 128 [63.1%] male) with stable coronary artery disease included in the study were grouped into four study groups according to their estimated glomerular filtration rate (eGFR) values. Multiplatetest was used to determine AR. Platelet aggregation results were presented as aggregation unit (AU) × min and valuesover 300 AU × min were accepted as AR.

Results: 61 (30.04%) patients in the whole study population were found to have AR. Differences were detected between AR ratios and multiplate values of the patient groups (p = 0.006 and p = 0.002). AR ratio was highest in patient group 4 (eGFR < 30 mL/min/1.73 m2) and/or on chronic haemodialysis therapy, whereas there was little difference amongthe other three groups. In multivariate analysis, while AR status was independently related to female sex (OR = 2.31,CI 1.14–4.65, p = 0.019) and mean platelet volume (MPV) (OR = 1.68, CI 1.21–2.33, p = 0.002), multiplate test results were independently related to MPV (b = 0.265, p < 0.0001) and eGFR (b = –0.165, p = 0.025).

Conclusions: The AR ratio was found to be high in severe CKD patients, especially haemodialysis patients, but not in mild and moderate CKD patients. This increased AR ratio in severe CKD patients may affect the prognosis in patients who already have an increased risk for cardiovascular complications.

Abstract

Background: Cardiovascular diseases (CVD) are the leading cause of death in patients with chronic kidney diseases (CKD). Aspirin resistance (AR) worsens prognosis in CVD.

Aim: The aim of this study was to detect AR prevalence in this patient group.

Methods: The 203 patients (mean age 61.84 ± 11.51 years, 128 [63.1%] male) with stable coronary artery disease included in the study were grouped into four study groups according to their estimated glomerular filtration rate (eGFR) values. Multiplatetest was used to determine AR. Platelet aggregation results were presented as aggregation unit (AU) × min and valuesover 300 AU × min were accepted as AR.

Results: 61 (30.04%) patients in the whole study population were found to have AR. Differences were detected between AR ratios and multiplate values of the patient groups (p = 0.006 and p = 0.002). AR ratio was highest in patient group 4 (eGFR < 30 mL/min/1.73 m2) and/or on chronic haemodialysis therapy, whereas there was little difference amongthe other three groups. In multivariate analysis, while AR status was independently related to female sex (OR = 2.31,CI 1.14–4.65, p = 0.019) and mean platelet volume (MPV) (OR = 1.68, CI 1.21–2.33, p = 0.002), multiplate test results were independently related to MPV (b = 0.265, p < 0.0001) and eGFR (b = –0.165, p = 0.025).

Conclusions: The AR ratio was found to be high in severe CKD patients, especially haemodialysis patients, but not in mild and moderate CKD patients. This increased AR ratio in severe CKD patients may affect the prognosis in patients who already have an increased risk for cardiovascular complications.

Get Citation

Keywords

aspirin resistance, coronary artery disease, chronic kidney disease

About this article
Title

Aspirin resistance in patients with impaired renal functions

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 72, No 4 (2014)

Pages

331-338

Published online

2014-04-09

DOI

10.5603/KP.a2013.0286

Bibliographic record

Kardiol Pol 2014;72(4):331-338.

Keywords

aspirin resistance
coronary artery disease
chronic kidney disease

Authors

Hale Unal Aksu
Ender Oner
Mehmet Erturk
Huseyin Aksu
Nilgun Isıksacan
Begum Ozalp
Gulsah Akture
Ertan Akbay
Leyla Ozer
Mustafa Kemal Erol

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Sp. z o.o. VM Group Sp.k., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl